Jamie Haney
Family · Greensboro, ALNPI 1801372149
Payments from drug & device makers
Across 246 payments — averaging $19.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$643
- Novo Nordisk$596
- Vanda Pharmaceuticals Inc.$458
- Johnson & Johnson$457
- Corium, LLC$448
- Medtronic$393
- plus $2K from 23 others
What the payments were for
- Travel & lodging$521%
- Food & beverage$4,72799%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $643 |
| Novo Nordisk | 35 | $596 |
| Vanda Pharmaceuticals Inc. | 22 | $458 |
| Johnson & Johnson | 22 | $457 |
| Corium, LLC | 20 | $448 |
| Medtronic | 6 | $393 |
| Alkermes, Inc. | 18 | $299 |
| GSK | 15 | $260 |
| Lilly USA, LLC | 13 | $205 |
| Otsuka America Pharmaceutical, Inc. | 11 | $192 |
| AstraZeneca | 9 | $149 |
| Novartis | 8 | $143 |
| Ironshore Pharmaceuticals Inc. | 5 | $104 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $69 |
| Tris Pharma Inc | 3 | $54 |
| Pfizer | 2 | $33 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Exact Sciences | 2 | $31 |
| Atland Pharmaceuticals, LLC | 1 | $30 |
| Jazz Pharmaceuticals Inc. | 2 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
How this compares
$4,779 in reported general payments places this provider in the 90th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 112 | $113,121 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 83 | $63,923 |
| FarxigaDapagliflozin Propanediol | 46 | $55,676 |
| RybelsusSemaglutide | 35 | $51,078 |
| JardianceEmpagliflozin | 27 | $31,092 |
| EliquisApixaban | 27 | $28,618 |
| MounjaroTirzepatide | 24 | $26,157 |
| JanuviaSitagliptin Phosphate | 15 | $21,610 |
| XareltoRivaroxaban | 34 | $20,728 |
| MyrbetriqMirabegron | 23 | $14,684 |
| VascepaIcosapent Ethyl | 11 | $9,238 |
| LinzessLinaclotide | 11 | $8,522 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $6,228 |
| SymbicortBudesonide/Formoterol Fumarate | 24 | $5,098 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 85 | $2,335 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $596 | $164,199147 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $260 | $70,15197 claims |
| AstraZenecaFarxiga, Symbicort | $149 | $60,77470 claims |
| PfizerEliquis | $33 | $28,61827 claims |
| Lilly USA, LLCMounjaro | $205 | $26,15724 claims |
| Johnson & JohnsonXarelto | $457 | $20,72834 claims |
| AbbVieLinzess | $643 | $8,52211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,415 family providers in Alabama.
Other family in Greensboro
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
- Kellyn McMahonBirmingham$39K
- Ashley StinesTuscaloosa$29K
- Brandy YoungMontgomery$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.